The regulation of synthesis of the gluconeogenic cytosolic enzyme phosphoenolpyruvate carboxykinase (PEPCK) and of tyrosine aminotransferase (TAT) by glucagon and glucocorticoid hormones was studied in hepatocytes maintained in suspension culture for 7 h. Specific antibodies were used to measure relative rates of enzyme synthesis after pulse-labelling of the cells with [3H]leucine or [35S]methionine. Concomitantly, amounts of mRNA were quantified after translation in vitro in a reticulocyte lysate and specific immunoprecipitation of the proteins. Glucagon stimulated the rate of synthesis of PEPCK by 4-6-fold and that of TAT by 6-8-fold in 2 h. In contrast, dexamethasone had little effect on PEPCK synthesis, whereas it increased TAT synthesis by 5-9-fold. When used in combination, the two hormones displayed additive effects on TAT synthesis, whereas the glucocorticoid hormone strongly potentiated stimulation of PEPCK synthesis by glucagon. In every instance, changes in rates of synthesis of the two enzymes were totally accounted for by increases in amounts of the corresponding functional mRNA, suggesting a pretranslational site of action for both glucagon and dexamethasone.
The regulation of synthesis of the gluconeogenic cytosolic enzyme phosphoenolpyruvate carboxykinase (PEPCK) and of tyrosine aminotransferase (TAT) by glucagon and glucocorticoid hormones was studied in hepatocytes maintained in suspension culture for 7 h. Specific antibodies were used to measure relative rates of enzyme synthesis after pulse-labelling of the cells with [3H]leucine or [35S]methionine. Concomitantly, amounts of mRNA were quantified after translation in vitro in a reticulocyte lysate and specific immunoprecipitation of the proteins. Glucagon stimulated the rate of synthesis of PEPCK by 4-6-fold and that of TAT by 6-8-fold in 2 h. In contrast, dexamethasone had little effect on PEPCK synthesis, whereas it increased TAT synthesis by 5-9-fold. When used in combination, the two hormones displayed additive effects on TAT synthesis, whereas the glucocorticoid hormone strongly potentiated stimulation of PEPCK synthesis by glucagon. In every instance, changes in rates of synthesis of the two enzymes were totally accounted for by increases in amounts of the corresponding functional mRNA, suggesting a pretranslational site of action for both glucagon and dexamethasone.
Tyrosine aminotransferase (EC 2.6.1.5) and the cytosolic form of phosphoenolpyruvate carboxykinase (GTP) (EC 4.1.1.32) are well-known inducible enzymes of the mammalian liver. Both have been under intensive investigation as model systems to understand the regulation of specific gene expression in the liver, especially as regards the mechanisms of action of cyclic AMP and the glucocorticoids. In the rat, glucagon causes a stimulation of the synthesis of tyrosine aminotransferase and phosphoenolpyruvate carboxykinase, resulting in increased enzyme activities (Wicks et al., 1969; Hanson et al., 1973 (Iynedjian & Hanson, 1977; Ernest & Feigelson, 1978; Noguchi et al., 1978; Beale et al., 1982; Cimbala et al., 1982) . Tyrosine aminotransferase mRNA and its relative rate of synthesis are also rapidly increased after a single administration of cortisol (Roewekamp et al., 1976; . The glucocorticoids, however, appear to be less effective inducers of hepatic phosphoenolpyruvate carboxykinase in vivo. A moderate stimulation of phosphoenolpyruvate carboxykinase synthesis has been noted in the diabetic, but not in the normal, animal after glucocorticoid administration (Gunn et al., 1975) .
Since the synthesis rates of tyrosine aminotransferase and phosphoenolpyruvate carboxykinase are controlled in vivo by cyclic AMP, the glucocorticoids, as well as several additional effectors (for reviews, see Tilghman et al., 1976; P. B. lynedjian, P. Auberger, Y. Guigoz and A. Le Cam cells in suspension culture were shown to respond to glucagon or cyclic AMP by a rapid induction of phosphoenolpyruvate carboxykinase synthesis, an effect markedly enhanced in the presence of dexamethasone (Salavert & lynedjian, 1982) . This prompted us to undertake similar studies on the regulation of tyrosine aminotransferase, especially in view of conflicting reports on the inducibility of this enzyme in isolated hepatocytes (Ernest et al., 1977; Gurr & Potter, 1980; Auberger et al., 1983) . The present paper describes the effects of glucagon and dexamethasone on the amounts of mRNA species coding for tyrosine aminotransferase and phosphoenolpyruvate carboxykinase and on the relative rates of synthesis of the two enzymes. The specific issues that we have addressed pertain to a possible translational control of hepatic enzyme synthesis by cyclic AMP (Wicks, 1974) and to the interaction of the glucocorticoids with the cyclic AMP system in the regulation of gene expression.
Materials and methods

Materials
Crystallized highly purified pig glucagon was generously given by Dr Tyrosine aminotransferase was purified as described by Hargrove et al. (1980) . Before its utilization for rabbit immunization, the purified protein was submitted to electrophoresis in a 10%-polyacrylamide gel containing SDS, in order to separate the subunit of tyrosine aminotransferase form I from proteolytic fragments which formed during storage of the enzyme. After electrophoresis, the gel was soaked for 20min in 4M-sodium acetate and viewed under fluorescent light to localize protein bands (Higgins & Dahmus, 1979) . The band containing the intact enzyme subunit was cut out from the gel, crushed in phosphatebuffered saline and the gel paste was mixed with an equal volume of complete Freund's adjuvant. White rabbits were injected with approx. 0.2mg of protein/animal at several intradermal sites. Intradermal booster injections were administered 3 weeks later, followed by two subsequent intramuscular injections at 3-week intervals. Immune sera were obtained 6 days after the last booster shot. Liver-cell isolation Hepatocytes were isolated by perfusion of the liver with collagenase essentially as described by Seglen (1976) . Before the experiments, male Wistar rats weighing about 160g were starved for 20h and subsequently re-fed with lOg of glucose/ kg body wt. by gavage. Surgery for liver perfusion was performed under pentobarbital anaesthesia 2 h after re-feeding. The liver was initially flushed in situ with 150ml of lOmM-Hepes [4-(2-hydroxy-ethyl)-l -piperazine-ethanesulphonic acid] buffer, pH7.6, containing heparin (100 units/ml) and EGTA (0.6mM), followed by 150ml of Hepes buffer alone. Collagenase was then perfused for 6min at 50ml/min in a recirculating circuit at a concentration of 0.5 mg/ml in a solution containing lOmM-CaCl2. All buffers were equilibrated with C02/02 (1:19) and perfused at 37°C. At the end of the perfusion, the cells were dissociated and washed as described by Salavert & Iynedjian (1982) . Cells were cultured in suspension for 7-8h in 250ml Erlenmeyer flasks containing 60ml of a medium defined previously (Salavert & Iynedjian, 1982) , to which was added 2mM-sodium pyruvate. The cell density was approx. 106 cells/ml of medium. Viability estimated by Trypan Blue exclusion was better than 90% at the end of the experiments. Pulse-labelling of cells Cells were withdrawn from incubation flasks, washed once in amino acid-free incubation medium and transferred to amino acid freemedium containing 250yuCi of [35S]methionine/ml or 400 4uCi of [3H]leucine/ml. Routinely, 750 x 103 cells were labelled in a volume of 0.3 ml. Labelling was terminated after 15min by centrifuging the cells (200g for 2min) and washing in ice-cold nonradioactive medium. Thereafter, cells were resuspended in 0.17 ml of a solution containing 25mM-potassium phosphate, pH7.8, 0.12M-KCl, 0.1 mM-pyridoxal phosphate, 1 mM-dithiothreitol, 1 mM-a-oxoglutaric acid (homogenization buffer), supplemented with 0.1 mM-phenylmethanesulphonyl fluoride. Cells were disrupted by three cycles of freezing-thawing.
Indirect immunoprecipitation of tyrosine aminotransferase and phosphoenolpyruvate carboxykinase Cellular homogenates were centrifuged at of high-speed supernatant. After pelleting of the beads by centrifugation (800g, 5min), the supernatant was removed and the beads were washed with 2 x 0.125 ml of cold homogenization buffer. All the supernatants were then pooled (vol. 0.4 ml) and divided into two samples for immune precipitation, 0.260ml for tyrosine aminotransferase and 0.130ml for phosphoenolpyruvate carboxykinase. Antibodies in amounts sufficient to neutralize about twice the amounts of enzyme present in the cell extract were added together with Triton X-405 (final concn. 0.6%). The mixtures were incubated at 37°C for 1 h. An excess of protein ASepharose CL 4B was then added, and incubation was continued with end-over-end agitation for 3 h at 4°C. Protein A-Sepharose was pelleted by centrifugation (800g, 5min) and the supernatant was removed. The beads were washed with 5 x 0.6 ml of homogenization buffer containing 5 mM-methionine or 5 mM-leucine and 0.6% Triton X-405. After two more washes with phosphatebuffered saline, electrophoresis sample buffer containing SDS and P-mercaptoethanol was added to the beads, and immune complexes were eluted and dissociated by incubation at 100°C for 10min. The supernatants obtained after pelleting of the beads were loaded on SDS/polyacrylamide slab gels prepared as described by Laemmli (1970) or on cylindrical gels prepared as described by Weber & Osborn (1969 (Salavert & lynedjian, 1982) . Total cellular RNA was translated in a commercial mRNA-dependent rabbit reticulocyte-lysate system, under conditions specified by the manufacturer. Routinely, the reaction volume was 75pl containing 30pl of lysate and 15,ug of RNA. Incubation was at 36°C for 60min. Thereafter, reaction mixtures were diluted by adding 90p1 of homogenization buffer and centrifuged at 10000Ogmax. for 20min at room temperature. The high-speed supernatant was pre-adsorbed for 30min at 4°C with 30u1 of packed protein ASepharose 6 MB and then used sequentially for indirect immunoprecipitations of newly synthesized tyrosine aminotransferase and phosphoenolpyruvate carboxykinase. Anti-(tyrosine aminotransferase) antiserum was added first and the mixture was incubated for 1 h at 37°C and 3 h at 4°C. The mixture was transferred on to 45 il of packed protein A-Sepharose 6 MB and the incubation continued for 45min at 37°C with frequent mixing. The affinity beads were collected by centrifugation (800g, 5 min), and subsequently washed and eluted in electrophoresis sample buffer as described above. The supernatant was utilized for indirect immunoprecipitation of phosphoenolpyruvatecarboxykinase by the same procedure. Products eluted from the protein A-Sepharose adsorbent were analysed by SDS/polyacrylamide-gel electrophoresis as described above. In control experiments, the supernatant left after immunoprecipitation of the two enzymes was analysed by high-resolution two-dimensional gel electrophoresis as described by O'Farrell (1975) and found to be virtually totally depleted of tyrosine aminotransferase and phosphoenolpyruvate carboxykinase translation products, demonstrating that immunoprecipitation was quantitative. Samples of high-speed supernatant from translation mixtures were used for analysis of the overall pattern of products by one-or twodimensional gel electrophoresis.
Results
Glucagon and dexamethasone effects on enzyme rates of synthesis
The rates of synthesis of tyrosine aminotransferase and phosphoenolpyruvate carboxykinase were measured by indirect immunoprecipitation of the enzymes from cell extracts prepared after pulselabelling of hepatocytes with [35S]methionine. The antibodies to phosphoenolpyruvate carboxykinase have been characterized previously (lynedjian & Jacot, 1980; Salavert & Iynedjian, 1982) . The specificity of the rabbit antiserum against tyrosine aminotransferase is demonstrated in Fig. 1 . Total labelled cytosol proteins (tracks 1 and 2) and immunoadsorbed polypeptides (tracks 3 and 4) from control cells and cells challenged with glucagon are displayed after electrophoresis in a SDS/polyacrylamide slab gel. The antibodies recognize a major polypeptide with apparent Mr 55000 and a minor polypeptide with apparent Mr 51 000. These polypeptides correspond respectively to the subunits of forms I and III of tyrosine aminotransferase, as defined by Hargrove et al. (1980) . These investigators showed that subunit form III is derived from form I by proteolytic cleavage during tissue homogenization and that proteolysis can be largely prevented by using the homogenization buffer described in the Materials and methods section. Clearly, radioactive amino Vol. 225 incorporation into total cytosol proteins was measured by trichloroacetic acid precipitation. Incorporation into both enzymes was measured immunochemically as shown in Fig. 1 for tyrosine aminotransferase, except that immunoadsorbed proteins were electrophoresed in cylindrical SDS/polyacrylamide gels and appropriate slices of the gels were cut for radioactivity measurements. Data from these induction experiments are presented in Table 1 . The relative rate of synthesis of tyrosine aminotransferase was increased 6-8-fold 2h after addition of glucagon. In the same cells, phosphoenolpyruvate carboxykinase synthesis was induced 4-6-fold. Previous work has shown that 0.4jM-glucagon is a maximal concentration for phosphoenolpyruvate carboxykinase induction and that enzyme synthesis virtually reaches a plateau 2h after hormone addition (Salavert & Iynedjian, 1982) . Dexamethasone caused a 5-9-fold increase in the relative rate of tyrosine aminotransferase synthesis, compared with a less than 2-fold stimulation of phosphoenolpyruvate carboxykinase synthesis. The effects of glucagon and dexamethasone on tyrosine aminotransferase synthesis were additive. Significantly, however, the stimulation of phosphoenolpyruvate carboxykinase synthesis by glucagon and dexamethasone together was supra-additive, reflecting a synergism between the two inducers.
Glucagon and dexamethasone effects on enzyme mRNA amounts Tyrosine aminotransferase and phosphoenolpyruvate carboxykinase mRNA species were assayed translationally in a mRNA-dependent reticulocyte-lysate protein-synthesis system. Translation products encoded by total cellular RNA from hepatocytes induced with glucagon and dexamethasone were analysed by high-resolution two-dimensional gel electrophoresis. Fig. 2 shows the overall pattern of newly synthesized polypeptides (a) and the product reacting with antityrosine aminotransferase antibodies (b). The immunoreactive translation product migrates with an apparent pI of 5.5-5.9 and an apparent M, of 55 000. These values are in general agreement with published data (Hargrove et al., 1980; Hargrove & Granner, 1981) , although charge heterogeneity is more pronounced in the present experiment. This experiment confirmed the specificity of the anti-(tyrosine aminotransferase) antiserum and allowed us to identify the primary translation product of tyrosine aminotransferase mRNA in high-resolution two-dimensional gels containing total translation products (downward arrow, Fig. 2a) . The translation product of phosphoenolpyruvate carboxykinase mRNA (upward arrow, Fig. 2a ) has been similarly identified (lynedjian & Jacot, 1981 A comparison of the intensity of the two spots indicates that phosphoenolpyruvate carboxykinase is not synthesized more actively than tyrosine aminotransferase in the reticulocyte-lysate translation system. In the liver cell, on the contrary, the relative rate of synthesis of phosphoenolpyruvate carboxykinase synthesis is about twice that of tyrosine aminotransferase (see Table 1 ). performed in a 10%-polyacrylamide gel containing SDS: tracks 2-6, total released polypeptides; tracks 7-11, tyrosine aminotransferase immunoreactive products; tracks 12-16, phosphoenolpyruvate carboxykinase immunoreactive products. The RNA samples for translation were isolated from cells before hormonal stimulation (tracks 2, 7, 12), 2h after addition of glucagon (tracks 3, 8, 13), 2h after addition of dexamethasone (tracks 4, 9, 14), 2h after addition of glucagon plus dexamethasone (tracks 5, 10, 15) or after continued incubation in basal medium (tracks 6, 11, 16). Onequarter of the translation mixture was used for analysis of total polypeptides. The remainder was used sequentially for tyrosine aminotransferase and phosphoenolpyruvate carboxykinase immunoprecipitations. Track 1: total translation products in absence of exogenous RNA. M, markers were as in Fig. 1 . Fig. 3 . All RNA preparations tested directed the synthesis of a similar range of polypeptides (tracks 2-6). The presence of high-Mr products suggests that RNA degradation was not a problem in these experiments. Both glucagon and dexamethasone caused an increase in the amount of functional tyrosine aminotransferase mRNA, as evidenced by an increase in the synthesis of full-length immunoreactive tyrosine aminotransferase in the lysate system. The effects of the two hormones were comparable in magnitude and appeared roughly additive (Fig. 3 , tracks 7-11). In contrast, the effect of glucagon on phosphoenolpyruvate carboxykinase mRNA was more pronounced than that of dexamethasone. Furthermore, the combination of glucagon and dexamethasone appeared to cause a supra-additive build-up of phosphoenolpyruvate carboxykinase (Fig. 3, tracks 12-16 [35S]methionine incorporated in hot-trichloroacetic acid-precipitable material. Data from a representative experiment in which the rates of enzyme synthesis in vivo were also measured are presented in Table 2 . Glucagon and dexamethasone caused 5-and 6-fold increases in functional tyrosine aminotransferase mRNA respectively; joint stimulation by the two hormones resulted in a 14-fold induction of the mRNA. In comparison, functional phosphoenolpyruvate carboxykinase mRNA was increased nearly 6-fold by glucagon, about 2-fold by dexamethasone and more than 11-fold by glucagon plus dexamethasone. It is important to note that the increases in specific mRNA molecules caused by glucagon as well as dexamethasone were of sufficient magnitude to explain the stimulations of tyrosine aminotransferase and phosphoenolpyruvate carboxykinase synthesis seen in intact cells. Similar results were obtained in two additional experiments of the same design.
Discussion
Rat liver cells incubated as described here respond to glucagon by a 6-8-fold induction of tyrosine aminotransferase synthesis in 2 h. In induced cells, the amount of functional tyrosine aminotransferase mRNA is increased to the same extent as the relative rate of enzyme synthesis. This argues for an effect of glucagon, presumably mediated by cyclic AMP, on the transcription, processing, transport or stability of tyrosine aminotransferase mRNA, rather than for a primary (and selective) effect on the translation machinery of the hepatocytes. Earlier studies in vivo led to a similar conclusion, based on an increase in tyrosine aminotransferase mRNA in rat liver after administration of dibutyryl cyclic AMP (Ernest et al., 1977; Noguchi et al., 1978; Scherer et al., 1982) . Culpepper & Liu (1983) showed that 8-bromocyclic AMP induces a rapid accumulation of tyrosine aminotransferase mRNA in H-4 rat hepatoma cells. As in the present work, the increase in mRNA was adequate to explain the concomitant stimulation of enzyme synthesis. Together, these data provide firm evidence that the cyclic AMP-mediated stimulation of tyrosine aminotransferase synthesis in normal or tumoral liver cells is primarily due to a pretranslational mechanism. The results presented here also point to a pretranslational site of action for cyclic AMP in the regulation of phosphoenolpyruvate carboxykinase expression, in agreement with previous investigations in normal liver cells or H-4 hepatoma cells (Salavert & lynedjian, 1982; lynedjian & Salavert, 1983; Chrapkiewicz et al., 1982) . Indeed, Lamers et al. (1982) have reported direct evidence for an increase in the transcription rate of the cytosolic phosphoenolpyruvate carboxykinase gene in isolated nuclei from cyclic AMP-treated rats. It is tempting to speculate that the build-up of tyrosine aminotransferase mRNA reflects a similar transcriptional effect on the gene. Nevertheless, additional mechanisms, such as stabilization ofthe mRNA molecules, may also play a role in the cyclic AMP-dependent induction of the enzymes. Moreover, Noguchi et al. (1982) showed that the rate of tyrosine aminotransferase synthesis in rat liver could be maintained at the induced value by repeated injections of dibutyryl cyclic AMP, whereas amounts of tyrosine aminotransferase mRNA were returning to basal values. This suggested the possibility of a longer-term translational effect of cyclic AMP on the synthesis of tyrosine aminotransferase. This issue should be resolved by extended time-course experiments using cultured hepatocytes.
The synthesis of tyrosine aminotransferase is readily induced by dexamethasone in the present liver cell system, as a consequence of a comparable increase in cognate mRNA. A similar effect of the glucocorticoids occurs in HTC hepatoma cells and in vivo in rat liver (Roewekamp et al., 1976; Olsen et al., 1980; Scherer et al., 1982) . The glucocorticoid-receptor complex has been shown to bind with high affinity to specific DNA sequences in the promotor region of a glucocorticoid-inducible mammary-tumour-virus gene (Payvar et al., 1981; Pfahl, 1982) . Evidence indicates that binding of the hormone-receptor complex to these sites enhances the transcription of the gene concerned (Chandler et al., 1983; Pfahl et al., 1983) . Such a mechanism may account for the induction of tyrosine aminotransferase.
The amount of mRNA coding for phosphoenolpyruvate carboxykinase was increased only slightly in cells incubated with dexamethasone.
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